VANCOUVER, Oct. 12 /PRNewswire-FirstCall/ - Biotech Holdings reports that in connection with a review by the TSX Venture Exchange (the "Exchange") concerning compliance with the Exchange policy and requirements, which resulted in the Company's halt status on September 4, 2007, the Board of Directors of the Company has decided that it is in the best interest of the Company to apply to the Exchange to delist its shares on a voluntary basis from the Exchange. As such, the Company has applied to the Exchange to delist its shares on a voluntary basis from the Exchange in Canada while continuing trading of the Company's shares on the Over the Counter Bulletin Board in the United States. The Company continues to report to and be accountable to the British Columbia Securities Commission, the Alberta Securities Commission and the U.S. Securities Exchange Commission.
This release has been approved by the Board of Directors of Biotech Holdings.
Robert B. Rieveley, Pres.
On behalf of the Board of Directors
Any statements made in this release that are not based on historical fact are forward-looking statements. Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions and may differ materially from what is expressed.
CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 (toll-free) 8 a.m. to 4 p.m. Pacific time; For background information on Biotech Holdings, or to receive news updates, see www.biotechltd.com; The Company can be reached by calling (604) 295-1119
CONTACT: Austin Rand at Biotech Holdings, 1-888-216-1111 (toll-free) 8
a.m. to 4 p.m. Pacific time; For background information on Biotech
Holdings, or to receive news updates, see www.biotechltd.com; The Company
can be reached by calling (604) 295-1119
